While heart complications and COVID-19 have been something closely watched by experts, this study — published Sept. 28 in Nature — revealed that the COVID-19 virus attacks arterial immune cells and “sets off a dangerous immune response in plaque deposits linking the heart’s arteries. The resulting inflammation makes it easier for plaque to grow, rupture, and block blood flow to the brain and other organs,” according to the release.
The study authors examined the arteries of men and women who had previously been infected with COVID-19 and died as a result and detected the virus in their arteries as an immune response.
“Our findings provide for the first time a direct mechanistic link between COVID-19 infection and the heart complications it provokes,” Natalia Eberhardt, PhD, the lead study author and a postdoctoral fellow in the Department of Medicine at NYU Langone Health stated in the news release. “The virus creates a highly inflammatory environment that could make it easier for plaque to grow, rupture, and block blood flow to the heart, brain, and other key organs.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
